Novel molecules of the tnf receptor superfamily and uses therefor
CA 2304746 A1 · Owner: Busfield, Samantha J. · Inventors: Busfield, Samantha J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel TRL polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length TRL proteins the invention further provides , isolated TRL fusion proteins antigenic peptides and anti-TRL antibodies. The invention also provides TRL nucleic acid molecules recombinant expression , vectors containing a nucleic acid molecule of the invention host cells into , which the expression vectors have been introduced and non-human transgenic animals in which a TRL gene has been introduced or disrupted. Diagnostic screening and therapeutic methods utilizing compositions of the invention are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 25, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 25, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 25, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.